Supreme Court: No changes to mifepristone access as litigation continues in lower court
The U.S. Supreme Court issued an ruling Friday evening that will preserve the status quo for access to the abortion medication mifepristone pending the outcome of ongoing litigation that is now before the U.S.
Court of Appeals for the 5th Circuit. Conservative Justices Samuel Alito and Clarence Thomas opposed the decision in the 7-2 ruling, which was made pursuant to an emergency request by the U.S.
Department of Justice to block rulings by lower federal courts that would have severely restricted access to the drug. The legal battle continues to play out in the 5th Circuit, which is slated to hear oral arguments for the case, Alliance for Hippocratic Medicine v.
U.S. Food and Drug Administration, on May 17. The case was brought on appeal from the ruling by Judge Matthew Kacsmaryk of the U.S.
